Sai Life Sciences Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Krishnam Kanumuri
Chief executive officer
₹32.9m
Total compensation
CEO salary percentage | 92.4% |
CEO tenure | 20.6yrs |
CEO ownership | n/a |
Management average tenure | 3.9yrs |
Board average tenure | 19.3yrs |
Recent management updates
No updates
Recent updates
No updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | ₹1b |
Jun 30 2024 | n/a | n/a | ₹1b |
Mar 31 2024 | ₹33m | ₹30m | ₹828m |
Compensation vs Market: Krishnam's total compensation ($USD387.53K) is about average for companies of similar size in the Indian market ($USD479.05K).
Compensation vs Earnings: Insufficient data to compare Krishnam's compensation with company performance.
CEO
Krishnam Kanumuri (53 yo)
20.6yrs
Tenure
₹32,900,000
Compensation
Mr. Krishnam Raju Kanumuri serves as the Chief Executive Officer and Managing Director of SAI Life Sciences Ltd and has been its Director since May 1, 2004. Mr. Kanumuri joined Sai in 2004 as Vice Presiden...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman & Whole-Time Director | 25.9yrs | ₹25.78m | no data | |
CEO, MD & Director | no data | ₹32.90m | no data | |
Chief Financial Officer | no data | ₹43.70m | no data | |
Chief Operating Officer | 2.9yrs | ₹46.89m | no data | |
Senior VP of HR and Administration & Global Head of Human Resources | 2.9yrs | ₹12.52m | no data | |
Company Secretary | 16.7yrs | ₹3.65m | no data | |
Senior VP and Global Head of Process Research & Development | 4.9yrs | ₹18.79m | no data | |
Chief Quality Officer | no data | ₹7.35m | no data | |
Senior VP & Head of Safety | no data | ₹10.56m | no data | |
Senior VP and Head of Business Development Chemistry | no data | ₹43.77m | no data | |
Senior VP of Technology Transfer & Head of Manufacturing Systems | no data | ₹13.39m | no data | |
Vice President of Corporate Communication | no data | no data | no data |
3.9yrs
Average Tenure
52.5yo
Average Age
Experienced Management: SAILIFE's management team is considered experienced (3.9 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman & Whole-Time Director | 25.9yrs | ₹25.78m | no data | |
CEO, MD & Director | 20.6yrs | ₹32.90m | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Independent Director | less than a year | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Independent Director | 17.9yrs | ₹3.86m | no data |
19.3yrs
Average Tenure
73yo
Average Age
Experienced Board: SAILIFE's board of directors are seasoned and experienced ( 19.3 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/17 21:21 |
End of Day Share Price | 2024/12/17 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sai Life Sciences Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|